申请人:BARLAAM Bernard Christophe
公开号:US20090036440A1
公开(公告)日:2009-02-05
The invention concerns pyrimidine compounds of Formula I, or a pharmaceutically acceptable salt thereof,
where A
1
, A
2
A
3
, R
1
, n, R
2
, R
3
, and R
4
are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours or other proliferative conditions which are sensitive to the inhibition of EphB4 kinases.
本发明涉及公式I的嘧啶化合物或其药学上可接受的盐,其中A1,A2A3,R1,n,R2,R3和R4如描述中所定义。本发明还涉及制备这些化合物的方法,包含它们的制药组合物以及它们在制造抗增殖剂用药物中的应用,用于预防或治疗对EphB4激酶抑制敏感的肿瘤或其他增殖性疾病。